BlinkLab (ASX:BB1) has initiated a clinical study in partnership with US based Turning Pointe Autism Foundation. The data obtained during the course of this collaboration will be used to finalise the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024. BlinkLab is an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism. Read the ASX announcement:...
1
Report
No comment yet
- No more -
Sign in to post a comment
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
BlinkLab Ltd Stock Forum
no news besides the insider buy recently. any idea?
The data obtained during the course of this collaboration will be used to finalise the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024.
BlinkLab is an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism.
Read the ASX announcement:...
No comment yet